0001562180-19-003078.txt : 20190523 0001562180-19-003078.hdr.sgml : 20190523 20190523172611 ACCESSION NUMBER: 0001562180-19-003078 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190521 FILED AS OF DATE: 20190523 DATE AS OF CHANGE: 20190523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sandor Victor CENTRAL INDEX KEY: 0001620368 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16633 FILM NUMBER: 19851204 MAIL ADDRESS: STREET 1: C/O ARRAY BIOPHARMA INC. STREET 2: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC CENTRAL INDEX KEY: 0001100412 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841460811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 3033816600 MAIL ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-05-21 false 0001100412 ARRAY BIOPHARMA INC ARRY 0001620368 Sandor Victor C/O ARRAY BIOPHARMA INC. 3200 WALNUT STREET BOULDER CO 80301 false true false false Chief Medical Officer Common Stock 2019-05-21 4 M false 12600.00 3.65 A 250292.00 D Common Stock 2019-05-21 4 S false 12600.00 26.50 D 237692.00 D Stock Option (Right to Buy) 3.65 2019-05-21 4 M false 12600.00 0.00 D 2024-09-22 Common Stock 12600.00 139262.00 D These trades were made pursuant to a Rule 10b5-1 trading plan. The option vested in four equal annual installments beginning on September 22, 2015. Jason Haddock, attorney-in-fact for Victor Sandor 2019-05-23